Literature DB >> 16190777

Synthesis and pharmacological evaluation of 1H-imidazoles as ligands for the estrogen receptor and cytotoxic inhibitors of the cyclooxygenase.

Thomas Wiglenda1, Ingo Ott, Brigitte Kircher, Petra Schumacher, Daniela Schuster, Thierry Langer, Ronald Gust.   

Abstract

The 1H-imidazoles 7a-e were synthesized and tested for biological activity in vitro. The results pointed to a clear structure-activity relationship. The introduction of an ethyl chain at C5 of the 1,2,4-tris(4-hydroxyphenyl)-1H-imidazole 7a caused hormonal activity in estrogen receptor positive MCF-7-2a cells. An o-chlorine substituent in the phenolic rings at C2 and C4 as realized in 7b and 7c increased the antiproliferative effects against human breast cancer cell lines MCF-7 and MDA-MB 231. Additionally, both compounds showed strong inhibitory effects on cyclooxygenase enzymes. Therefore, a mode of action including the interference in the arachidonic acid cascade might be possible.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16190777     DOI: 10.1021/jm050190u

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Palladium-catalyzed N-monoarylation of amidines and a one-pot synthesis of quinazoline derivatives.

Authors:  Meredeth A McGowan; Camille Z McAvoy; Stephen L Buchwald
Journal:  Org Lett       Date:  2012-07-05       Impact factor: 6.005

2.  Thiophene-core estrogen receptor ligands having superagonist activity.

Authors:  Jian Min; Pengcheng Wang; Sathish Srinivasan; Jerome C Nwachukwu; Pu Guo; Minjian Huang; Kathryn E Carlson; John A Katzenellenbogen; Kendall W Nettles; Hai-Bing Zhou
Journal:  J Med Chem       Date:  2013-04-15       Impact factor: 7.446

3.  A Quick Access to Structurally Diverse Triazoloquinazoline Heterocycles via the MIL-101(Cr)-Catalyzed One-Pot Multi-Component Reaction of a Series of Benzaldehydes, Dimedone, and 1H-1,2,4-Triazol-3-Amine Under Green Conditions.

Authors:  Pezhman Shiri; Esmaeil Niknam; Jasem Aboonajmi; Ali Khalafi-Nezhad; Ali Mohammad Amani
Journal:  Front Chem       Date:  2022-07-25       Impact factor: 5.545

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.